Published April 2019
| Version v1
Journal article
Exposure to glucocorticoids prior to transcatheter aortic valve replacement is associated with reduced incidence of high-degree AV block and pacemaker
Creators
- 1. Department of Medicine, Division of Cardiology, University of Minnesota Medical School, Minneapolis, MN, United States of America (United States)
- 2. Minneapolis VA Healthcare System, Minneapolis, MN, United States of America (United States)
- 3. Department of Surgery, Division of Cardiothoracic Surgery, University of Minnesota Medical School, Minneapolis, MN, United States of America (United States)
- 4. Fairview Southdale Hospital, Edina, MN, United States of America (United States)
Description
Tissue edema and inflammation, which occur at the device landing zone during valve deployment, may contribute to the pathophysiology of conduction abnormalities after transcatheter aortic valve replacement (TAVR). We hypothesized that exposure to glucocorticoids prior to TAVR will reduce the incidence of conduction abnormalities requiring PPM implantation after TAVR.
Additional details
Identifiers
- DOI
- 10.1016/j.carrev.2018.07.012;
- PII
- S1553838918303117;
Publishing Information
- Journal Title
- Cardiovascular Revascularization Medicine (Print)
- Journal Volume
- 20
- Journal Issue
- 4
- Journal Page Range
- p. 328-331
- ISSN
- 1553-8389
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55055852
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANIMAL TISSUES; CARDIAC PACEMAKERS; EDEMA; GLUCOCORTICOIDS; INFLAMMATION; VALVES
- Descriptors DEC
- ADRENAL HORMONES; BODY; CONTROL EQUIPMENT; CORTICOSTEROIDS; EQUIPMENT; FLOW REGULATORS; HORMONES; HYDROXY COMPOUNDS; KETONES; ORGANIC COMPOUNDS; PATHOLOGICAL CHANGES; PREGNANES; STEROID HORMONES; STEROIDS; SYMPTOMS
Optional Information
- Notes
- Published by Elsevier Inc.